|
Volumn 50, Issue 5, 2001, Pages 1295-1298
|
Medication for hearing loss after fractionated stereotactic radiotherapy (SRT) for vestibular schwannoma
|
Author keywords
Hearing; Radiosurgery; Stereotactic radiotherapy; Steroid; Vestibular schwannoma
|
Indexed keywords
AUDITION;
IRRADIATION;
MEDICINE;
HEARING LOSS;
RADIOTHERAPY;
CORTICOSTEROID;
PREDNISONE;
ADULT;
AGED;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CONVALESCENCE;
DRUG EFFICACY;
FEMALE;
FOLLOW UP;
HEARING LOSS;
HUMAN;
MALE;
NEURILEMOMA;
PRIORITY JOURNAL;
PURE TONE AUDIOMETRY;
RADIATION DOSE FRACTIONATION;
SOUND INTENSITY;
VESTIBULAR DISORDER;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTI-INFLAMMATORY AGENTS;
AUDIOMETRY, PURE-TONE;
DOSE FRACTIONATION;
DRUG EVALUATION;
FEMALE;
FOLLOW-UP STUDIES;
HEARING LOSS, SENSORINEURAL;
HUMANS;
MALE;
MIDDLE AGED;
NEUROMA, ACOUSTIC;
PREDNISONE;
RADIATION INJURIES;
RADIOSURGERY;
RETROSPECTIVE STUDIES;
TREATMENT OUTCOME;
VESTIBULAR NERVE;
|
EID: 0035424109
PISSN: 03603016
EISSN: None
Source Type: Journal
DOI: 10.1016/S0360-3016(01)01574-7 Document Type: Article |
Times cited : (16)
|
References (9)
|